SCHOTT Pharma AG & Co. KGaA
Industry Group: Healthcare
Country/Region: Germany
Identifier: ETR:1SXP
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 199 out of 588
Universe
Global Universe 5627 out of 15080
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
SCHOTT Pharma AG & Co. KGaA |
22
Medium
|
199 out of 588 |
Ambu A/S |
22
Medium
|
201 out of 588 |
Getinge AB |
23.5
Medium
|
248 out of 588 |
PROCEPT BioRobotics Corp. |
29.4
Medium
|
390 out of 588 |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. |
35
High
|
561 out of 588 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
SCHOTT Pharma AG & Co. KGaA's Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
SCHOTT Pharma AG & Co. KGaA's Management of ESG Material Risk is Strong